Recon: Pfizer, BioNTech to develop mRNA shingles shot; French court backs class action over Sanofi’s Depakine drug
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy